Carborane compounds for neutron capture therapy of malignant melanoma
| dc.contributor.author | Wilson, JG | en_AU |
| dc.date.accessioned | 2025-12-15T06:47:21Z | en_AU |
| dc.date.available | 2025-12-15T06:47:21Z | en_AU |
| dc.date.issued | 1992 | en_AU |
| dc.date.statistics | 2025-11-24 | en_AU |
| dc.description | Physical copy held by ANSTO Library at DDC: 616.994/17 | en_AU |
| dc.description.abstract | The possibility of using thiouracil as a vehicle for stable nuclei such as 10B for neutron capture therapy (NCT) of melanoma was first discussed by Fairchild and co-workers in 1982. The author's research has been directed towards the design and synthesis of a number of o-carboranyl-thiouracils, the ten boron atoms of the carborane cage having a clear advantage for NCT. The first step was the preparation, previously reported, of thiouracils bearing an alkyl group continuing a triple bond for later elaboration to a carborane. The present paper describes the continuation of this work with the preparation of the carboranes of this series and its extension to the synthesis of a thiouracil in which a carboranylalkyl group is attached to the nitrogen in the 3-position. © Plenum Press. | en_AU |
| dc.identifier.citation | Wilson, J. G. (1992). Carborane compounds for neutron capture therapy of malignant melanoma. Paper presented to the Fourth International Symposium on Neutron Capture Therapy for Cancer, December 4-7, 1990, Sydney, Australia. In B. J. Allen, D. E. Moore, & B. V. Harrington (Eds.), Progress in Neutron Capture Therapy for Cancer (pp. 227-230). Springer US. New Your, USA: Plenum Press. | en_AU |
| dc.identifier.conferenceenddate | 1990-12-07 | en_AU |
| dc.identifier.conferencename | Fourth International Symposium on Neutron Capture Therapy for Cancer | en_AU |
| dc.identifier.conferenceplace | Sydney, Australia | en_AU |
| dc.identifier.conferencestartdate | 1990-12-04 | en_AU |
| dc.identifier.editors | B. J. Allen, D. E. Moore, & B. V. Harrington | en_AU |
| dc.identifier.isbn | 0306441047 | en_AU |
| dc.identifier.journaltitle | Progress in Neutron Capture Therapy for Cancer | en_AU |
| dc.identifier.pagination | 227-230 | en_AU |
| dc.identifier.placeofpublication | New York, USA | en_AU |
| dc.identifier.uri | https://apo.ansto.gov.au/handle/10238/16797 | en_AU |
| dc.language.iso | en | en_AU |
| dc.publisher | Plenum Press | en_AU |
| dc.subject | Biological localization | en_AU |
| dc.subject | Boron 10 | en_AU |
| dc.subject | Carboranes | en_AU |
| dc.subject | Chemical bonds | en_AU |
| dc.subject | Melanomas | en_AU |
| dc.subject | Molecular structure | en_AU |
| dc.subject | Neutron capture therapy | en_AU |
| dc.subject | Synthesis | en_AU |
| dc.subject | Thiouracil | en_AU |
| dc.title | Carborane compounds for neutron capture therapy of malignant melanoma | en_AU |
| dc.type | Conference Paper | en_AU |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.63 KB
- Format:
- Item-specific license agreed upon to submission
- Description: